RecruitingNot applicableNCT05923333

B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Cape Town
Principal Investigator
Heather Jaspan, MD PHD
Seattle Children's Hospital
Intervention
B. infantis Rosell®-33(dietary_supplement)
Enrollment
200 enrolled
Eligibility
50 years · All sexes
Timeline
2023 – 2027

Study locations (1)

Collaborators

Seattle Children's Hospital · University of Stellenbosch · Institute for Systems Biology · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · University of Washington

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05923333 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency →

← Back to all trials